PAION AG is a publicly listed specialty pharmaceutical company developing and aiming to commercialize innovative drugs for out-patient and hospital-based sedation, anesthesia and critical care services.

 

Learn more About PAION

news

10/22/2020

PAION Insights Newsletter October 2020

PAION Insights Newsletter October 2020

Read more
10/06/2020

PAION REPORTS PROGRESS WITH BYFAVO (REMIMAZOLAM) BY ITS LICENSEE ACACIA IN THE...

DGAP-News: PAION AG / Key word(s): Miscellaneous06.10.2020 /...

Read more
09/25/2020

Presentation Baader Investment Conference September 2020

Presentation Baader Investment Conference September 2020

Read more

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.